Therefore, it was surprising that circulating TNFα concentration was reduced in the GBM group compared to healthy controls (p < 0.001), especially when we take into account the meta-analysis by Feng et al. [52], which showed that elevated circulating TNFα level was associated with an increased glioma risk. The gene discussed is TNF; the disease is central nervous system cancer.